Nuveen Asset Management, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2019. The put-call ratio across all filers is 0.38 and the average weighting 0.4%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q2 2024$1,559,819
+24.7%
92,957
+11.4%
0.00%
Q1 2024$1,251,2850.0%83,4190.0%0.00%
Q4 2023$1,251,285
+40.4%
83,419
+31.1%
0.00%
Q3 2023$891,512
+40.1%
63,634
+3.5%
0.00%
Q2 2023$636,132
-25.5%
61,462
-35.1%
0.00%
Q1 2022$854,000
-5.7%
94,660
+1.0%
0.00%
Q4 2021$906,000
-45.9%
93,752
-6.5%
0.00%
-100.0%
Q3 2021$1,674,000
+13.5%
100,316
+3.8%
0.00%
Q2 2021$1,475,000
-26.2%
96,600
-5.9%
0.00%
-100.0%
Q1 2021$2,000,000
-43.9%
102,654
-48.1%
0.00%0.0%
Q4 2020$3,562,000
-23.1%
197,690
-17.7%
0.00%
-50.0%
Q3 2020$4,635,000
-47.4%
240,248
-28.7%
0.00%
-50.0%
Q2 2020$8,807,000
+82.3%
337,149
+24.5%
0.00%
+100.0%
Q1 2020$4,831,000
+346.1%
270,833
+496.0%
0.00%
Q3 2019$1,083,000
-29.6%
45,444
+6.1%
0.00%
-100.0%
Q2 2019$1,539,00042,8260.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2019
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 789,297$39,275,00060.44%
Wildcat Capital Management, LLC 251,459$12,513,0009.57%
Consonance Capital Management LP 1,487,491$74,018,0004.77%
MENORA MIVTACHIM HOLDINGS LTD. 2,499,870$124,394,0003.53%
MEITAV INVESTMENT HOUSE LTD 509,355$29,967,0001.34%
DSAM Partners (London) Ltd 127,588$6,349,0001.28%
SHIKIAR ASSET MANAGEMENT INC 48,125$2,395,0001.00%
BANK HAPOALIM BM 67,125$3,340,0000.91%
HIGHLINE CAPITAL MANAGEMENT, L.P. 331,900$16,515,0000.55%
Clal Insurance Enterprises Holdings Ltd 310,000$15,426,0000.40%
View complete list of UROGEN PHARMA LTD shareholders